PMID- 11032950
OWN - NLM
STAT- MEDLINE
DCOM- 20001130
LR  - 20190605
IS  - 1021-335X (Print)
IS  - 1021-335X (Linking)
VI  - 7
IP  - 6
DP  - 2000 Nov-Dec
TI  - Orofacial viral infections in the immunocompromised host.
PG  - 1389-94
AB  - Orofacial viral infections are common in immunocompromised patients. Herpes 
      simplex virus (HSV) infections are the most common. Varicella-Zoster virus (VZV) 
      infections are less common, but usually more severe. Epstein-Barr virus (EBV) may 
      produce ulcers, lymphoproliferative syndromes or oral hairy leukoplakia (HL). 
      Human herpes virus 6 (HHV 6) may be the etiology of recurrent aphthous 
      stomatitis, while human herpes virus 7 (HHV 7) has an unclear role. Human herpes 
      virus 8 (HHV 8) is the etiologic agent of Kaposi sarcoma. Human papilloma viruses 
      (HPVs) cause warts, papillomas and epithelial hyperplasia. Molluscum contagiosum 
      is caused by a poxvirus. All herpes viruses (HSV, VZV, CMV, EBV, HHV 6, HHV 7, 
      HHV 8) and many HPVs are associated with neoplasias. Research is ongoing to 
      clarify the role of other viruses in the development of infections and lesions in 
      the orofacial area.
FAU - Samonis, G
AU  - Samonis G
AD  - Division of Medicine, The University of Crete, 711 10 Heraklion, Crete, Greece. 
      georgsec@med.uch.gr
FAU - Mantadakis, E
AU  - Mantadakis E
FAU - Maraki, S
AU  - Maraki S
LA  - eng
PT  - Journal Article
PT  - Review
PL  - Greece
TA  - Oncol Rep
JT  - Oncology reports
JID - 9422756
SB  - IM
MH  - Facial Dermatoses/diagnosis/*immunology/therapy/virology
MH  - Herpesviridae Infections/diagnosis/*immunology/therapy
MH  - Humans
MH  - *Immunocompromised Host
MH  - Mouth Diseases/diagnosis/*immunology/therapy/virology
MH  - Neoplasms/immunology/virology
MH  - Oral Hygiene/methods
RF  - 80
EDAT- 2000/10/18 11:00
MHDA- 2001/02/28 10:01
CRDT- 2000/10/18 11:00
PHST- 2000/10/18 11:00 [pubmed]
PHST- 2001/02/28 10:01 [medline]
PHST- 2000/10/18 11:00 [entrez]
AID - 10.3892/or.7.6.1389 [doi]
PST - ppublish
SO  - Oncol Rep. 2000 Nov-Dec;7(6):1389-94. doi: 10.3892/or.7.6.1389.